In patients with COVID-19, the expression of tissue-residency markers (CD69 and CD103) and activation markers (PD-1 and HLA-DR) is higher in airway CD8+ T cells than in their peripheral blood counterparts [108], indicating that tissue-resident CD8+ T cells with an activated phenotype are enriched in the airways. The gene discussed is CD8A; the disease is COVID-19.